Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) Share Price Falls 3.68% Today

Glaxosmithkline Pharmaceuticals Ltd. Share Price fell 3.68% today, closing at Rs 2,550. The company's market capitalisation stands at Rs 45,014.57 crore.

Glaxosmithkline Pharmaceuticals Ltd. Share Price experienced a significant decline today, falling by 3.68% to close at Rs 2,550. This decline comes as the company, with a market capitalisation of Rs 45,014.57 crore, witnessed a notable shift in its stock performance. The share price opened at Rs 2,645 and reached a high of the same value before declining to a low of Rs 2,508.5. The total volume traded today was 55,862 shares, with a turnover of Rs 1.19 crore. This movement places Glaxosmithkline Pharmaceuticals Ltd.

The decline in Glaxosmithkline Pharmaceuticals Ltd.'s share price today highlights a notable shift in market sentiment. Despite the absence of a specific catalyst in the supplied data, the significant drop in price warrants attention from investors and analysts alike. The company's position in the Healthcare sector, coupled with its large market capitalisation, makes this event particularly relevant for market participants. As investors seek to understand the implications of this price movement, a closer examination of the technical and fundamental aspects of the company is essential.

Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 2,550
Previous Close	Rs 2,647.45
Today's Change	Rs -97.45 (-3.68%)
Day Open	Rs 2,645
Day High	Rs 2,645
Day Low	Rs 2,508.5
Current Volume (BSE)	4,672
BSE Traded Volume	4,672
NSE Traded Volume	51,190
Combined NSE + BSE Volume	55,862
Turnover	Rs 1.19 crore
Market Capitalisation	Rs 45,014.57 crore
Market Cap Category	Large Cap

Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) traded at Rs 2,550. versus the previous close of Rs 2,647.45, a fall of 3.68%. The stock opened at Rs 2,645, reached Rs 2,645, touched Rs 2,508.5. Reported volume was 4,672.

Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 45,014.57 crore

Glaxosmithkline Pharmaceuticals Ltd. holds a market capitalisation of Rs 45,014.57 crore, positioning it as a significant player in the Healthcare sector. The company's valuation metrics, such as P/E and P/B ratios, are crucial in understanding its market position.The Healthcare sector's P/E median is 26.29, with an average of 91.55, indicating a wide range of valuations within the industry.

The company's return on equity (ROE) and return on capital employed (ROCE) are essential indicators of financial performance. The sector's ROE median is 10.77%, and the ROCE median is 13.35%, providing a benchmark for evaluating Glaxosmithkline Pharmaceuticals Ltd.'s profitability. Although specific ROE and ROCE values for the company are not available, these sector benchmarks offer a reference point for analysis.

In terms of market capitalisation, Glaxosmithkline Pharmaceuticals Ltd. stands well above the sector's median of Rs 136.63 crore, highlighting its substantial presence in the industry. The company's financial metrics, when compared to sector averages, will be critical in assessing its valuation and investment potential. Investors will be closely monitoring these fundamentals to gauge the company's long-term prospects.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Benchmark Median P/E	26.29x
Benchmark Average P/E	91.55x
Benchmark P/E Range	3.39x to 3,385.56x
Benchmark Median P/B	1.9x
Benchmark Median ROE	10.77%
Benchmark Median ROCE	13.35%
Company Market Capitalisation	Rs 45,014.57 crore
Benchmark Median Market Cap	Rs 136.63 crore

Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) is classified under sector: Healthcare.

Track today's top decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Glaxosmithkline Pharmaceuticals Ltd. operates within the Healthcare sector, which comprises 198 companies. The sector's P/E median is 26.29, with an average of 91.55, reflecting a diverse range of valuations. The P/B median is 1.9, and the average is 2.57, indicating varying levels of book value among companies. The sector's ROE median is 10.77%, and the ROCE median is 13.35%, providing benchmarks for profitability analysis.

Within this context, Glaxosmithkline Pharmaceuticals Ltd.'s market capitalisation of Rs 45,014.57 crore positions it as a major player, significantly above the sector's median of Rs 136.63 crore. The company's valuation and performance metrics, when compared to sector benchmarks, will be crucial in understanding its competitive position. The Healthcare sector's dynamics, including regulatory changes and market trends, will continue to influence the company's performance and investor sentiment.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,945.17	30.21	0.44	-2.89	-0.26
Hikal Ltd.	HIKAL	2,835.92	0	2.35	15.22	16.15
Kwality Pharmaceuticals Ltd.	KPL	2,652.68	39.86	8.11	28.21	26.35
Beta Drugs Ltd.	BETA	2,608.51	63.2	10	18.65	22.17
Panacea Biotec Ltd.	PANACEABIO	2,589.99	0	3.07	0	5.36

Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a market capitalisation of Rs 45,014.57 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

In the Healthcare sector, Glaxosmithkline Pharmaceuticals Ltd. faces competition from several peers. Dishman Carbogen Amcis Ltd. has a market cap of Rs 2,945.17 crore with a P/E of 30.21. Hikal Ltd. has a market cap of Rs 2,835.92 crore and a P/B of 2.35. Kwality Pharmaceuticals Ltd. boasts a P/E of 39.86 and a market cap of Rs 2,652.68 crore. Beta Drugs Ltd. has a P/E of 63.2 and a market cap of Rs 2,608.51 crore. These comparisons highlight the diverse valuation metrics within the sector and provide a context for Glaxosmithkline Pharmaceuticals Ltd.'s market position.

Why Investors Are Watching Glaxosmithkline Pharmaceuticals Ltd.

Investors are closely monitoring Glaxosmithkline Pharmaceuticals Ltd. due to its recent price fall and its significant position in the Healthcare sector. The company's large market capitalisation and the notable decline in share price have drawn attention from market participants.

• Price Action: 3.68% decline today, closing at Rs 2,550.
• Technical Position: Significant price movement in the Large Cap category.
• Fundamental Context: Strong market capitalisation in the Healthcare sector.
• Sector Positioning: Operates in a dynamic and competitive sector.

As the market continues to evolve, investors will be watching for any developments that could impact Glaxosmithkline Pharmaceuticals Ltd.'s performance and market position. The company's ability to navigate sector trends and maintain its competitive edge will be key areas of focus.

About Glaxosmithkline Pharmaceuticals Ltd.

Glaxosmithkline Pharmaceuticals Ltd. is a prominent player in the Healthcare sector, focusing on pharmaceuticals and drugs. The company operates in a competitive industry, providing a range of healthcare solutions. Its substantial market capitalisation of Rs 45,014.57 crore underscores its significant presence in the sector. As a leader in the industry, Glaxosmithkline Pharmaceuticals Ltd. continues to innovate and deliver products that cater to various healthcare needs. The company's strategic initiatives and market positioning are crucial in maintaining its competitive advantage and driving growth in the ever-evolving healthcare landscape.

Track Glaxosmithkline Pharmaceuticals Ltd. Share Price on Univest

Use Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners lists and related market analysis.

Investors can track Glaxosmithkline Pharmaceuticals Ltd. Share Price on Univest to stay updated with live price movements, technical indicators, and fundamental ratios. Univest provides insights into the company's shareholding pattern, 52-week levels, and market trends, offering a comprehensive view of the stock's performance. Stay informed with Univest's detailed analysis and market insights.

Frequently Asked Questions

What caused Glaxosmithkline Pharmaceuticals Ltd. Share Price to fall today?

Ans. The supplied data confirms a 3.68% price fall today, but no specific catalyst was identified. The company's large market capitalisation and sector dynamics may have influenced the decline. The stock moved -3.68% during the session.

How does Glaxosmithkline Pharmaceuticals Ltd. compare to its peers?

Ans. Compared to peers like Dishman Carbogen Amcis Ltd. and Hikal Ltd., Glaxosmithkline Pharmaceuticals Ltd. has a larger market cap. Peer P/E and ROE metrics vary widely. Comparable listed companies include Dishman Carbogen Amcis Ltd., Hikal Ltd., Kwality Pharmaceuticals Ltd.

What is the sector context for Glaxosmithkline Pharmaceuticals Ltd.?

Ans. Glaxosmithkline Pharmaceuticals Ltd. operates in the Healthcare sector, which has a P/E median of 26.29 and an ROE median of 10.77%, providing benchmarks for analysis. The stock belongs to the Healthcare sector.

How can investors track Glaxosmithkline Pharmaceuticals Ltd. Share Price?

Ans. Investors can track Glaxosmithkline Pharmaceuticals Ltd. Share Price on Univest for live updates, technical indicators, and market insights, providing a comprehensive view of the stock. The stock moved -3.68% during the session.